Actavis Said to Have Spurned $15 Billion Offer

May 14 (Bloomberg) -- Actavis rejected a cash-and-stock offer from fellow generic drugmaker Mylan for $15 billion, deciding instead to pursue talks to take over Warner Chilcott, said people familiar with the matter. Bloomberg's Jeff McCracken reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)

ConocoPhillips CEO Says Cenovus Deal Great for Company
43:20 - ConocoPhillips CEO Ryan Lance discusses oil prices and Cenovus’ acquisition of ConocoPhillips’s 50% interest in the FCCL Partnership, their oil sands JV. He speaks with Alix Steel on “Bloomberg Markets.” (Source: Bloomberg)
  • Determining the Oil Market's Path of Least Resistance
  • UBS's Dennis Sees Trade Risks for Emerging Markets
  • Bloomberg Brief Weekly Video 03/30